Oxford: Owner of Tommy Bahama, Lilly Pulitzer and Johnny Was Reports First Quarter Results

Why It Matters

These results highlight the pressure on mid‑tier apparel brands from tariffs and soft consumer sentiment, while the narrowed guidance signals a more cautious outlook for investors. The dividend continuity underscores Oxford’s commitment to shareholder returns despite earnings headwinds.

Key Takeaways

• Tommy Bahama sales up 3.9% to $224.6 M.
• Lilly Pulitzer sales fell 8.8% to $90.4 M.
• Adjusted EPS $1.39, below prior year, includes $0.55 tariff impact.
• Full-year sales guidance narrowed to $1.475‑$1.505 B.
• Dividend declared $0.70 per share, continuing since 1960.

Pulse Analysis

Oxford Industries posted a near‑flat first‑quarter top line, with consolidated net sales of $391 million, essentially matching the $393 million recorded a year earlier. The modest performance masks divergent trends across its portfolio: Tommy Bahama posted a 3.9 % increase to $224.6 million, while Lilly Pulitzer and Johnny Was saw declines of 8.8 % and 12.9 % respectively. The mixed results reflect lingering macro‑economic headwinds—weak consumer sentiment, higher energy prices, and lingering tariff pressures—that continue to weigh on discretionary apparel spending in the United States.

On a profitability basis, adjusted earnings per share fell to $1.39 from $1.82 a year ago, with $0.55 of that decline directly attributed to incremental tariff costs. Gross margin slipped to 62.3 % from 64.2 % as higher cost‑of‑goods and a $4 million LIFO charge eroded profitability, although the company partially offset the hit through updated sourcing, lower freight expenses, and a higher proportion of direct‑to‑consumer sales. SG&A rose to $211 million, driven by new brick‑and‑mortar openings, food‑and‑beverage concepts, and software investments aimed at modernizing the merchandising and marketing engine.

Looking ahead, Oxford trimmed the upper bound of its full‑year sales guidance to $1.505 billion while lifting the low end of its EPS range, signaling a more defensive stance amid uncertain demand. Capital expenditures are expected to fall to roughly $60 million for the year, down from $108 million, as the firm prioritizes inventory discipline and cost control. The board’s decision to maintain a $0.70 per share dividend—unchanged since 1960—offers a steady income stream for shareholders, but investors will be watching how corrective actions at Lilly Pulitzer and the broader DTC strategy influence earnings momentum.